ERBB2 and breast cancer: Unidentified serine proteases expressed in human breast cancer cell lines SKBR3 and BT474 had been implicated for a role in Her2 ECD shedding upon protein kinase C (PKC) activation, producing CTFs capable of activating downstream signaling [20].